PBS Biotech Expands Leadership Team and Secures $17 Million in Growth Capital to Accelerate Delivery of Next Generation Cell and Regenerative Therapies [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
CAMARILLO, Calif. Jan. 6, 2025 /PRNewswire/ -- PBS Biotech ("PBS"), a provider of innovative single-use bioreactor systems and bioprocess development services, has secured $17 million in follow-on growth capital from Avego Management, LLC ("Avego") and BroadOak Capital Partners ("BroadOak"). This investment will accelerate PBS' new product innovation, process development services, and quality system improvements, further advancing the cell therapy industry and helping their customers bring life-saving therapies to market faster. PBS Biotech Logo (PRNewsfoto/PBS Biotech Inc.) The company is also expanding its ISO 9001:2015 manufacturing capacity, which will be completed by mid-2025, to support more than $100 million in annual revenue and to demonstrate readiness to meet customers' demands as they scale up from clinical trials to regulatory approval and commercialization. PBS is excited to welcome Terrell Mathews as Chief Commercial Officer and Erik Wiberg as Chief Financial Offi
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Medical Affairs Outsourcing Market Analysis Report 2024-2033: Increase in Patent Expirations, Advancements in Communication Methods, and the Burgeoning Life Sciences Industry Fueling Growth [Yahoo! Finance]Yahoo! Finance
- Microplate Systems Market to Reach Revenues of $3.6 Billion by 2034, at a CAGR of 11.02% - Thermo Fisher Scientific, PerkinElmer, and Danaher Corporation (Molecular Devices) Dominate [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific Inc. (NYSE: TMO) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Key Trends and Growth Opportunities in the Laboratory Animal Models, 3D Cultures, and Organoids Market [Yahoo! Finance]Yahoo! Finance
- Cell Therapy and Gene Therapy CDMO Market to Reach USD 11.11 Billion by 2030 | Discover Growth Trends and Insights | Valuates Reports [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 10/23/24 - Beat
TMO
Sec Filings
- 1/2/25 - Form 4
- 1/2/25 - Form 4
- 1/2/25 - Form 4
- TMO's page on the SEC website